The connection domain in reverse transcriptase facilitates the in vivo annealing of tRNALys3 to HIV-1 genomic RNA

Retrovirology

Volumn 1, Issue , 2004, Pages

  Cen, Shan ^a,b   Niu, Meijuan ^b   Kleiman, Lawrence ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GENOMIC RNA; RIBONUCLEOPROTEIN; RNA DIRECTED DNA POLYMERASE; SYNTHETASE; TRANSFER RNA; LYSINE TRANSFER RNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; DNA PACKAGING; GENE SEQUENCE; GENE TARGETING; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION; SEQUENCE ANALYSIS; VIRUS ASSEMBLY; VIRUS GENOME; ANIMAL; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; GENE DELETION; GENETIC TRANSFECTION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PLASMID;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; GENOME, VIRAL; HIV REVERSE TRANSCRIPTASE; HIV-1; PLASMIDS; RNA, TRANSFER, LYS; RNA, VIRAL; SEQUENCE DELETION; TRANSFECTION;

EID: 18144396910     PISSN: 17424690     EISSN: None     Source Type: Journal    
DOI: 10.1186/1742-4690-1-33     Document Type: Article

References (32)

1. Jiang M, Mak J, Ladha A, Cohen E, Klein M, Rovinski B, Kleiman L: Identification of tRNAs incorporated into wild-type and mutant Human Immunodeficiency Virus Type 1. J Virol 1993, 67: 3246-3253.
2. Mak J, Kleiman L: Primer tRNAs for reverse transcription. J Virol 1997, 71:8087-8095.
3. Beerens N, Groot F, Berkhout B: Inititation of HIV-1 reverse transcription is regulated by a primer activation signal. J Biol Chem 2001, 276:31247-31256.
4. Lys3 (Template/Primer) Complex. J Mol Biol 1995, 247:236-250.
5. Dannull J, Surovoy A, Jung G, Moelling K: Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues. EMBO J 1994, 13:1525-1533.
6. De Rocquigny H, Gabus C, Vincent A, Fournie-Zaluski M-C, Roques B, Darlix J-L: Viral RNA annealing activites of Human Immunodeficiency Virus Type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc Natl Acad Sci USA 1992, 89:6472-6476.
7. Lys3 genomic placement and initiation of reverse transcription in HIV-1. J Virol 1998, 72: 3907-3915.
8. Phe: a lead ribozyme and 1H NMR study. Nucl Acid Res 1996, 24: 3568-3575.
9. Chan B, Weidemaier K, Yip W-T, Barbara PF, Musier-Forsyth K: Intra-tRNA Distance Measurements for Nucleocapsid Protein-Dependent tRNA Unwinding During Priming of HIV Reverse Transcription. Proc Natl Acad Sci USA 1999, 96:459-464.
10. Tisne C, Roques BP, Dardel F: Heteronuclear NMR studies of the interaction of tRNA(Lys)3 with HIV-1 nucleocapsid protein. J Mol Biol 2001, 306:443-454.
11. Lys3 tertiary structural changes, but are not critical for primer/template annealing. J Mol Biol 2001, 312:987-999.
12. Lys3 on the viral genome exists in unextended and two base- extended forms within mature Human Immunodeficiency Virus Type 1. J Virol 1997, 71:726-728.
13. Crawford S, Goff SP: A deletion mutation in the 5′ part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins. J Virol 1985, 53: 899-907.
14. Stewart L, Schatz G, Vogt VM: Properties of avian retrovirus particles defective in viral protease. J Virol 1990, 64:5076-5092.
15. Lys3 genomic placement and the initiation step of reverse transcription in HIV-1. J Virol 2000, 74:11344-11353.
16. Lys3 to Human Immunodeficiency Virus Type 1 genomic RNA. J Virol 1999, 73: 4485-4488.
17. Feng YX, Campbell S, Harvin D, Ehresmann B, Ehresmann C, Rein A: The Human Immunodeficiency Virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site. J Virol 1999, 73:4251-4256.
18. Lys into HIV-1. J Mol 2000, 299:17-26.
19. Wu X, Liu H, Xiao H, Conway JA, Hunter E, Kappes JC: Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein. EMBO 1997, 16:5113-5122.
20. Arts EJ, Miller JT, Ehresmann B, Le Grice SF: Mutating a region of HIV-1 reverse transcriptase implicated in tRNA(Lys-3) binding and the consequences for (-)-strand DNA synthesis. J Biol Chem 1998, 273(23):14523-14532.
21. Lys3. J Mol Biol 1 999, 285(4):1339-1346.
22. Lys3 to Reverse Transcriptase from Human Immunodeficiency Virus Type 1. EMBO J 1995, 14: 2679-2687.
23. Araya A, Sarih L, Litvak S: Reverse transcriptase mediated binding of primer tRNA to the viral genome. Nucleic Acids Res 1979, 6:3831-3843.
24. Lys3 to reverse transcriptase of the Human Immunodeficiency Virus Type 1. J Biol Chem 1995, 270: 23867-23874.
25. Cen S, Niu M, Saadatmand J, Guo F, Huang Y, Nabel GJ, Kleiman L: Incorporation of pol into human immunodeficiency virus type 1 Gag virus- like particles occurs independently of the upstream Gag domain in Gag-pol. J Virol 2004, 78:1042-1049.
26. Javanbakht H, Halwani R, Cen S, Saadatmand J, Musier-Forsyth K, Gottlinger HG, Kleiman L: The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly. J Biol Chem 2003, 278:27644-27651.
27. Huang Y, Kong W-P, Nabel GJ: Human immunodeficiency virus type I- specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. J Virol 2001, 75: 4947-4951.
28. Qiu JT, Song R, Dettenhofer M, Tian C, August T, Felber BK, Pavlakis GN, Yu XF: Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses. J Virol 1999, 73:9145-9152.
29. Lys into Human Immunodeficiency Virus Type 1 particles. J Virol 1994, 68:2065-2072.
30. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochemistry 1976, 72: 248-254.
31. Chomczynski P, Sacchi N: RNA isolation from cultured cells. Analytical Biochemistry 1987, 162:156-159.
32. Lys3 into HIV-1. J Virol 1994, 68:7676-7683.